• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cassava Sciences Inc (NQ: SAVA )

    26.14 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cassava Sciences Inc

    < Previous 1 2
    ...
    27 28 29 30 31 32 33 34 Next >
    2 High-Risk, High-Reward Stocks That Could Go to the Moon
    Risk-averse investors may want to look elsewhere. 
    Via The Motley Fool
    61 Biggest Movers From Yesterday
    Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's... 
    Via Benzinga
    Here's Why Cassava Sciences Is Surging Today
    Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference. 
    Via The Motley Fool
    Exposures Product Safety
    SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars
    SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Chembio Diagnostics (NASDAQ:CEMI) stock rose 189.72% to $5.97 during Wednesday's regular session. Trading volume for Chembio Diagnostics's stock is 265.3... 
    Via Benzinga
    38 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to... 
    Via Benzinga
    Building A Bear-Proof Portfolio: Investing Safely Up As The Fear & Greed Index Approaches Early 2020 Levels.
    Market Fear Gauge Approaches 2020 Levels As ZeroHedge reported on Monday, the Fear & Greed gauge has approached early 2020 levels. Screen capture via... 
    Via Benzinga
    Here's Why Cassava Sciences Is Up 1,152% in the First Half of 2021
    This small-cap biotech has shot up in value as the company's Alzheimer's drug makes it way through clinical trials. 
    Via The Motley Fool
    Is Now The Time To Buy Stock In Cassava Sciences, Facebook Or Apple?
    One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
    Via Benzinga
    Why Is Cassava Sciences Stock Soaring in 2021?
    The stock market is excited by the clinical trial results for its Alzheimer's drug. 
    Via The Motley Fool
    10 Biggest Price Target Changes For Tuesday
    Citigroup boosted International Business Machines Corporation (NYSE: 
    Via Benzinga
    Building A Bear-Proof Portfolio
    How to invest confidently as the Fear & Greed gauge hits early 2020 fear levels. 
    Via Talk Markets
    Understanding Cassava Sciences's Unusual Options Activity
    Cassava Sciences (NASDAQ:SAVA) shares experienced unusual options activity on Friday. The stock price moved down to $79.73 following the option alert. Sentiment: BEARISH Option... 
    Via Benzinga
    54 Biggest Movers From Yesterday
    Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share. Cinedigm Corp. (NASDAQ: CIDM)... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Why Cassava Sciences Stock Moved Higher Monday
    The biotech stock bounced back big Monday after tumbling on Friday. 
    Via The Motley Fool
    38 Stocks Moving In Monday's Mid-Day Session
    Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in... 
    Via Benzinga
    24 Stocks Moving in Monday's Pre-Market Session
    Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares rose 67.7% to $16.42 in pre-market trading after jumping around 280% on Friday. MER Telemanagement Solutions Ltd. (NASDAQ: MTSL)... 
    Via Benzinga
    64 Biggest Movers From Friday
    Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval
    Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval. 
    Via Investor's Business Daily
    Exposures Product Safety
    Follow the Money to Find Out What's Working This Year
    The notorious dip-buyers have been aggressively supporting this market ever since the pandemic low point last year. If they become fully invested, the flow of new money into the market could stop. 
    Via Talk Markets
    Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
    Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P... 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
    Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ... 
    Via Benzinga
    This Biotech Stock Is Beating GameStop
    Now the question is whether the gains are here to stay. 
    Via The Motley Fool
    Is It Too Late to Buy Cassava Sciences Stock?
    Just because the stock has had a massive run doesn't mean its biggest gains are behind it. 
    Via The Motley Fool
    PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
    On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ... 
    Via Benzinga
    Alzheimer’s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    Could Cassava Sciences Be a Millionaire-Maker Stock?
    Can this biotech underdog develop an Alzheimer's drug investors can count on? 
    Via The Motley Fool
    44 Biggest Movers From Yesterday
    Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume... 
    Via Benzinga
    The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
    Via Benzinga
    < Previous 1 2
    ...
    27 28 29 30 31 32 33 34 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.